NIDA POLICY UPDATE FOR CAREER DEVELOPMENT AWARDS (K AWARDS)

Release Date:  August 5, 1999

P.T.

National Institute on Drug Abuse

PURPOSE

This supplement to the National Institutes of Health (NIH) Career Development
Program Announcements (K Awards) is intended to provide additional information 
for potential applicants on the unique aspects of National Institute on Drug 
Abuse (NIDA) career development programs.  The NIH program announcements 
addressed in this supplement are the following:

PA-95-049:  Mentored Research Scientist Development Award (K01)
PA-95-050:  Independent Scientist Award (K02)
PA-95-051:  Senior Scientist Award (K05)
PA-95-053:  Mentored Clinical Scientist Development Award (K08)
PA-95-054:  Mentored Clinical Scientists Development Program Award (K12)
PA-98-052:  Mentored Patient-Oriented Research Career Development Award (K23)
PA-98-053:  Midcareer Investigator Award in Patient-Oriented Research (K24)

The guidelines and procedures outlined in NIH program announcements must be 
followed closely when an application is being prepared for submission to the
NIDA.  Particular attention should be paid to the purpose of each award mechanism,
its eligibility requirements, and its review considerations.

This notice consolidates, replaces, and supersedes all previous NIDA notices,
including:

1. NIDA Supplemental Information to the NIH Career Development Program 
2. Announcements (K Awards) NIH Guide, Vol. 26, No.5, February 14,1997

Supplemental Information for NIDA Applicants

The RESEARCH OBJECTIVES section of each program announcement should be 
followed carefully during the preparation of an application.  Note especially
that differences exist among various NIH Institutes regarding allowable costs.  
The unique aspects of NIDA allowable costs, specifically in the categories 
of salary (all Ks) and research development support (K01, K08, and K23), 
are listed below.

Salary (K01, K02, K05, K08, K12, K23, K24)

Effective October 1, 1999, this policy applies to all new (type 1), competitive 
renewal (type 2), and non-competitive renewal (type 5) applications.  The NIDA
contribution to the principal investigator�s salary is geared to institutional 
base salary as follows:

Institutional Base Salary        NIDA Contribution
Up to $48,000                    100% of institutional base salary
$48,001 to $64,000               $48,000
$64,001 and over                 75% of institutional base salary, up to $90,000

Research Development Support (K01, K08, K23)

NIDA allows for funds up to $50,000 per year for research-related costs
outlined in each program announcement.

Research Support (K02, K05, K24):

For the K02 and K05 awards, NIDA allows for funds up to $25,000 per year for
those applications from individuals who are engaged in predominantly theoretical
work, such as modeling or computer simulation, as outlined in each program 
announcement.

For the K24 award, NIDA will provide up to $25,000 per year for research
expenses; such as supplies, equipment, technical personnel, travel, and statistical
services.

Renewals:

K01, K08, and K23 Awards:

Support for the K01, K08, and K23 awards are limited to one term of 3 to 5
years and are further restricted to one mentored career award per individual.

K02 and K24:

The Independent Scientist Award (K02) and Midcareer Investigator Award in
Patient-Oriented Research (K24) are renewable one time only.

Eligibility Requirements (K01)

A candidate for the Mentored Research Scientist Development Award (K01) may
not concurrently apply for any other PHS award that duplicates the provisions of
this award nor have another application pending award.



Inquiries:

Consultation with NIDA staff is encouraged especially during the planning
phase of the application.  Below are the names of the NIDA staff who can 
provide further information:

NIDA Institute Coordinator

Andrea Baruchin, Ph.D.
Office of Science Policy and Communications
(301) 443-6071
(301) 443-6277 (fax)
E-mail:  [email protected]

Lucinda L. Miner, Ph.D.
Deputy Research Training Coordinator
Office of Science Policy and Communications
(301) 443-6071
(301) 443-6277 (fax)
E-mail:  [email protected]

For Programmatic Issues:

Division of Basic Research

Charles W. Sharp, Ph.D.
(301) 443-1887
(301) 594-6043 (fax)
E-mail:  [email protected]

Division of Clinical and Services Research

Arthur Horton, Ed.D.
(301) 443-4877
(301) 443-2317 (fax)
E-mail:  [email protected]

Division of Epidemiology and Prevention Research

Kathy Etz, Ph.D.
(301) 443-1514
(301) 443-2636 (fax)
E-mail:  [email protected]

Center On Aids And Other Medical Consequences Of Drug Abuse

Jag Khalsa, Ph.D.
(301) 443-1801
(301) 594-6566 (fax)
E-mail:  [email protected]

For Review Issues:

Office Of Extramural Program Review

Mark Swieter, Ph.D. 
(301) 443-2755
(301) 443-0538 (fax)
E-mail: [email protected]

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)